Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NDUFB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DYNC1I2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CXCR4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PCDH9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRPSAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF641 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IFT52 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TLR4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IRF8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FLJ32255 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
SQRDL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DDX27 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RALBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDR91 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM86B3P - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANLN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VPS50 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KHDRBS3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARHGAP17 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on